Roche Holding AG (MEX:ROG N) Moat Score : 9/10 (As of Jul. 06, 2025)

View and export this data going back to 2013. Start your Free Trial

What is Roche Holding AG Moat Score?

Roche Holding AG has the Moat Score of 9, which implies that the company might have Wide Moat - Clear and robust wide moat.

Roche Holding AG has Wide Moat: Roche Holding has a dominant position in pharmaceuticals with strong intellectual property, significant regulatory barriers, and a robust R&D pipeline. The company benefits from strong brand strength and pricing power.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Roche Holding AG might have Wide Moat - Clear and robust wide moat.

Competitive Comparison of Roche Holding AG's Moat Score

For the Drug Manufacturers - General subindustry, Roche Holding AG's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG's Moat Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Moat Score distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Moat Score falls into.

Save Embed

;

Save Embed

;

Roche Holding AG (MEX:ROG N) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score	Moat Level
10	Wide Moat - Exceptionally dominant and durable wide moat
8 - 9	Wide Moat - Clear and robust wide moat
7	Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6	Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5	Narrow Moat - Solid narrow moat
4	Narrow Moat - Discernible but modest moat
1 - 3	No Moat - Very weak/transient advantages
0	No Moat - No discernible moat

Roche Holding AG Moat Score Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (MEX:ROG N) » Definitions » Moat Score

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBY:USA RHHBF:USA 1ROG:Italy 1RO:Italy ROz:UK ROGz:UK 0TDF:UK 0QQ6:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland ROG:Canada ROCH:Austria

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG Headlines

No Headlines